Asthma drugs and the risk of congenital anomalies

Pharmacotherapy

Volumn 33, Issue 4, 2013, Pages 363-368

  Vasilakis Scaramozza, Catherine ^a   Aschengrau, Ann ^a   Cabral, Howard J ^a   Jick, Susan S ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Congenital anomalies; Prevalence rates; Relative risk

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG; STEROID;

ADULT; ARTICLE; ASTHMA; BIRTH WEIGHT; CLEFT LIP; CLEFT PALATE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; MACROSOMIA; MAJOR CLINICAL STUDY; MUSCULOSKELETAL DISEASE; NEWBORN; OBESITY; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PREVALENCE; RISK ASSESSMENT;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; CASE-CONTROL STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE;

EID: 84879545540     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1213     Document Type: Article

References (20)

1. Stenius-Aarniala BSM, Hedman J, Teramo KA. Acute asthma during pregnancy. Thorax 1996;51:411-414.
2. Tan KS, Thomson NC. Asthma in pregnancy. Am J Med 2000;109:727-733.
3. Schatz M. Asthma treatment during pregnancy. What can be taken safely. Drug Saf 1997;16:342-350.
4. Lin S, Herdt-Losavio M, Gensburg L, Marshall E, Druschel C. Maternal asthma, asthma drug use, and the risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol 2009;85:161-168.
5. Lin S, Munsie JP, Herdt-Losavio ML, et al. Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol 2008;168:73-79.
6. Sørensen HT, Pedersen L, Nørgaard M, Wogelius P, Rothman KJ. Maternal asthma, preeclampsia and risk of hypospadias. Epidemiology 2005;16:806-807.
7. Blais L, Beauchesne MF, Rey E, Malo JL, Forget A. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax 2007;62:320-328.
8. Silverman M, Sheffer A, Diaz PV, et al. Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide. Ann Allergy Asthma Immunol 2005;95:566-570.
9. Nelson-Piercy C. Asthma in pregnancy. Thorax 2001;56: 325-328.
10. Rodŕguez-Pinilla E, Mart́nez-Fŕas ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 1998;58:2-5.
11. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007;197:585.e1-7; discussion 683-4, e1-7.
12. Jick H, Jick S, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-768.
13. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992;1:347-349.
14. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-425.
15. Jick SS, Kaye JA, Vasilakis-Scaramozza C. Garcia Rodríguez LA, Ruigómez A, Meier CR, Schlienger RG, Black C, Jick H. Validity of the general practice research database. Pharmacotherapy 2003;23:686-689.
16. Jick SS, Terris BZ. Anticonvulsants and congenital malformations. Pharmacotherapy 1997;17:561-564.
17. Jick SS. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy 1999;19(2):221-222.
18. Pharoah POD, Glinianaia SV, Rankin J. Congenital anomalies in multiple births after early loss of a conceptus. Hum Reprod 2009;24(3):726-731.
19. Glinianaia SV, Rankin J, Wright C. Congenital anomalies in twins: a register-based study. Hum Reprod 2008;23(6):1306-1311.
20. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM. National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2003 Mar;67 (3):193-201.